Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice
Viruses · 2023
DOI: 10.3390/v15020432 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Siva K Gandhapudi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY 40506, USA. Hauptthemen laut MEDLINE: COVID-19, RNA, Viral. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Adjuvants are essential components of subunit vaccines added to enhance immune responses to antigens through immunomodulation. Very few adjuvants have been approved for human use by regulatory agencies due to safety concerns. Current subunit vaccine adjuvants approved for human use are very effective in promoting humoral immune responses but are less effective at promoting T-cell immunity. In this study, we evaluated a novel pure enantio-specific cationic lipid 1,2-dioleoyl-3-trimethylammonium-propane (R-DOTAP) as an immunomodulator for subunit vaccines capable of inducing both humoral- and cellular-mediated immunity. Using recombinant protein antigens derived from SARS-CoV2 spike or novel computationally optimized broadly reactive influenza antigen (COBRA) proteins, we demonstrated that R-DOTAP nanoparticles promoted strong cellular- and antibody-mediated immune responses in both monovalent and bivalent vaccines. R-DOTAP-based vaccines induced antigen-specific and polyfunctional CD8+ and CD4+ effector T cells and memory T cells, respectively. Antibody responses induced by R-DOTAP showed a balanced Th1/Th2 type immunity, neutralizing activity and protection of mice from challenge with live SARS-CoV2 or influenza viruses. R-DOTAP also facilitated significant dose sparing of the vaccine antigens. These studies demonstrate that R-DOTAP is an excellent immune stimulator for the production of next-generation subunit vaccines containing multiple recombinant proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY 40506, USA.
- PDS Biotechnology Corporation, Florham Park, NJ 07932, USA.
- Center for Influenza Vaccine Research for High Risk Populations, University of Georgia, Athens, GA 30602, USA.
- Center for Vaccines and Immunology and Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA.
ORCID-Profile: Siva K Gandhapudi, Ted M Ross
Förderung
- NIAID NIH HHS
- NIH HHS
- NCI NIH HHS
- the National Institute of Allergy and Infectious Diseases
- the National Institutes of Health
- the University of Kentucky Flow Cytometry & Immune Monitoring core facility
- the Office of the Vice President for Research
- the Markey Cancer Center and an NCI Center Core
Zitieren
APA
Gandhapudi, S. K., Shi, H., Ward, M. R., Bush, J. P., Avdiushko, M., Sundarapandiyan, K., Wood, L. V., Dorrani, M., Fatima, A., Dervan, J., Bedu-Addo, F., Conn, G., Ross, T. M., & Woodward, J. G. (2023). Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice. Viruses. https://doi.org/10.3390/v15020432
Vancouver
Gandhapudi SK, Shi H, Ward MR, Bush JP, Avdiushko M, Sundarapandiyan K, et al. Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice. Viruses. 2023. doi:10.3390/v15020432
BibTeX
@article{Gandhapudi2023,
author = {Gandhapudi, Siva K and Shi, Hua and Ward, Martin R and Bush, John Peyton and Avdiushko, Margarita and Sundarapandiyan, Karuna and Wood, Lauren V and Dorrani, Mania and Fatima, Afsheen and Dervan, Joe and Bedu-Addo, Frank and Conn, Greg and Ross, Ted M and Woodward, Jerold G},
title = {Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15020432}
}
EUVIMED